146 related articles for article (PubMed ID: 26176272)
21. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus.
Shi P; Liu W; Zhou ZT; He QB; Jiang WW
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):844-9. PubMed ID: 20200437
[TBL] [Abstract][Full Text] [Related]
22. Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513.
Salphati L; Plise EG; Li G
Eur J Pharm Sci; 2009 Jun; 37(3-4):463-8. PubMed ID: 19491037
[TBL] [Abstract][Full Text] [Related]
23. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
[TBL] [Abstract][Full Text] [Related]
24. ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer.
Palshof JA; Cederbye CN; Høgdall EVS; Poulsen TS; Linnemann D; Nygaard SB; Stenvang J; Christensen IJ; Jensen BV; Pfeiffer P; Brünner N; Yilmaz M; Viuff BM; Nielsen DL
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708825
[TBL] [Abstract][Full Text] [Related]
25. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
[TBL] [Abstract][Full Text] [Related]
26. Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines.
Moon HH; Kim SH; Ku JL
Oncol Rep; 2016 Jan; 35(1):298-306. PubMed ID: 26497773
[TBL] [Abstract][Full Text] [Related]
27. [Correlation of MDR1 and ABCG2 genetic polymorphisms with the efficacy and adverse events of irinotecan chemotherapy in patients with colorectal cancer].
Sun ZW; Wang XC; Gao J; Li J; Li YY; Dang YZ; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):524-8. PubMed ID: 23801203
[TBL] [Abstract][Full Text] [Related]
28. ABCG2 localizes to the nucleus and modulates CDH1 expression in lung cancer cells.
Liang SC; Yang CY; Tseng JY; Wang HL; Tung CY; Liu HW; Chen CY; Yeh YC; Chou TY; Yang MH; Whang-Peng J; Lin CH
Neoplasia; 2015 Mar; 17(3):265-78. PubMed ID: 25810011
[TBL] [Abstract][Full Text] [Related]
29.
Sałagacka-Kubiak A; Zawada D; Saed L; Kordek R; Jeleń A; Balcerczak E
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445716
[TBL] [Abstract][Full Text] [Related]
30. LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2.
Liu B; Guo Z; Dong H; Daofeng T; Cai Q; Ji B; Zhang S; Wu L; Wang J; Wang L; Zhu X; Liu Y; Chen Q
Brain Res; 2015 Jun; 1611():93-100. PubMed ID: 25801120
[TBL] [Abstract][Full Text] [Related]
31. Phorbol ester TPA modulates chemoresistance in the drug sensitive breast cancer cell line MCF-7 by inducing expression of drug efflux transporter ABCG2.
Kalalinia F; Elahian F; Hassani M; Kasaeeian J; Behravan J
Asian Pac J Cancer Prev; 2012; 13(6):2979-84. PubMed ID: 22938493
[TBL] [Abstract][Full Text] [Related]
32. [Expression of ATP-binding cassette transporter ABCG2 in gastric carcinoma and its significance].
Wang N; Chen L; Wei B; Zhao XY; Lu WJ; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):450-3. PubMed ID: 17851787
[TBL] [Abstract][Full Text] [Related]
33. Effect of oxygen on multidrug resistance in the first trimester human placenta.
Lye P; Bloise E; Dunk C; Javam M; Gibb W; Lye SJ; Matthews SG
Placenta; 2013 Sep; 34(9):817-23. PubMed ID: 23790363
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
[TBL] [Abstract][Full Text] [Related]
35. Protective role of ABCG2 against oxidative stress in colorectal cancer and its potential underlying mechanism.
Nie S; Huang Y; Shi M; Qian X; Li H; Peng C; Kong B; Zou X; Shen S
Oncol Rep; 2018 Oct; 40(4):2137-2146. PubMed ID: 30066914
[TBL] [Abstract][Full Text] [Related]
36. High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.
Andersen V; Vogel LK; Kopp TI; Sæbø M; Nonboe AW; Hamfjord J; Kure EH; Vogel U
PLoS One; 2015; 10(3):e0119255. PubMed ID: 25793771
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of Breast Cancer Resistance Protein Expression was Decreased in Plasma Membrane of Colon Cancer with Metastasis of Lymphatic Node.
Wu A; Zhang J; Zeng L; Li F; Dong Z; Feng Y; Jia X; Jin JO; Zhang L
Clin Lab; 2018 Mar; 64(3):311-319. PubMed ID: 29739115
[TBL] [Abstract][Full Text] [Related]
38. Correlation between adenosine triphosphate (ATP)-binding cassette transporter G2 (ABCG2) and drug resistance of esophageal cancer and reversal of drug resistance by artesunate.
Wang L; Liu L; Chen Y; Du Y; Wang J; Liu J
Pathol Res Pract; 2018 Sep; 214(9):1467-1473. PubMed ID: 30104076
[TBL] [Abstract][Full Text] [Related]
39. Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material.
Diestra JE; Scheffer GL; Català I; Maliepaard M; Schellens JH; Scheper RJ; Germà-Lluch JR; Izquierdo MA
J Pathol; 2002 Oct; 198(2):213-9. PubMed ID: 12237881
[TBL] [Abstract][Full Text] [Related]
40. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]